Allergo-COMOD® suited for long-term therapy
and for sensitive eyes
A sustainable efficiency in the treatment of an allergic conjunctivitis can be achieved by eye drops containing the active substance cromoglicinic acid. This active substance already prevents the release of histamine and interferes in the allergic mechanisms at an earlier step.
The cromoglicinic acid is hardly absorbed by the human body, so it mainly counteracts where the distressing symptoms appear.
Side effects, such as tiredness which has been observed for other anti-allergic preparations, have not been found on this active substance. A reliable and sustainable protection is built up in long-term application.
- Allergo-COMOD® eye drops for the sensitive eye and long-term therapy
- Preservative free
- Ideal for light to moderate complaints
- Without age restrictions and very well tolerated.
Allergo-COMOD® – before allergy starts.
|Allergo-COMOD®||PZN||Shelf life after opening||Storage instructions|
|10 ml eye drops||04502974||12 weeks||Do not store at temperatures above 25 degrees Celsius|
Allergo-COMOD® eye drops 20 mg/ml eye drops
Active ingredient: sodium cromoglicate
Therapeutic indication: allergic, acute and chronic conjunctivitis e.g. hay-fever related conjunctivitis, spring catarrh (vernal keratoconjunctivitis).
For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. March 2013
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.